STAT Plus: Skin cancer immunotherapy could have potential but don’t hang hopes on new data
NIH
A reported tumor response rate from the company's combination treatment with Keytruda might be real and encouraging — or a short-lived, disappointing blip.
.png)
No hay comentarios:
Publicar un comentario